This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

SolarWinds says US SEC admission 'dooms' agency's fraud case against company, CSO

By Mike Swift ( May 20, 2024, 21:03 GMT | Insight) -- SolarWinds, the Texas company whose software was turned into a trojan horse that compromised thousands of other companies in a 2020 cyberattack engineered by a Russian intelligence agency, is trying to convince a federal judge in New York that the US Securities and Exchanged Commission damaged its case during a court hearing last week. SolarWinds says the SEC blew a hole in its case when it acknowledged that threat reports about malicious activity in SolarWinds’ Orion software did not clearly indicate a massive cyberattack was underway.SolarWinds hopes to convince a federal judge that the US Securities and Exchange Commission doomed its central litigation argument last week, when the regulator acknowledged in court that threat reports about the Texas company’s software did not clearly indicate a massive cyberattack was underway....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections